Monopar Therapeutics Inc. · NASDAQ:MNPR
Robinson Chandler reported a 4.50% stake in Monopar Therapeutics Inc. (Schedule 13D/A)
Event Jan 28, 2026 · Filed Jan 30, 2026
Robinson Chandler reported a 4.50% stake in Monopar Therapeutics Inc., 307,370 shares, with active intent on Jan 28, 2026. Filed Jan 30, 2026 (Schedule 13D/A).
- Stake
- 4.50%
- Shares
- 307,370
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Tactic Pharma LLC | 0% | 0 |
| Robinson Chandler | 4.50% | 307,370 |
| Brown Michael J | 1.80% | 124,629 |
Source
Related
- Monopar Therapeutics Inc.
- Robinson Chandler
- Monopar Therapeutics Inc. shareholders
- Schedule 13D/A · Robinson Chandler · Sep 24, 2025
- Form 4 · Robinson Chandler · Oct 20, 2026
- Form 4 · Starr Christopher M · Oct 5, 2026
- Form 4 · Cittadine Andrew · Oct 2, 2026
- Form 4 · Vu Quan Anh · Oct 2, 2026
- Form 4 · Robinson Chandler · Oct 2, 2026